UBS Trims P&G (PG) Price Target, Maintains Buy Rating

The Procter & Gamble Company (NYSE:PG) is one of the most profitable consumer stocks to buy now. UBS analyst Peter Grom lowered his price target on The Procter & Gamble Company (NYSE:PG) to $180 from $186 while maintaining a Buy rating, citing refined estimates ahead of the company’s fiscal fourth-quarter results. Despite the downward adjustment, the revised target still implies an upside of about 16% from the current price of $155.

The move reflects a more tempered near-term view rather than a shift in long-term confidence. UBS continues to see strength in P&G’s brand portfolio, which spans core categories like fabric care, grooming, and personal health. Grom noted that while foreign exchange pressures and consumer trade-down behavior are worth watching, the company’s pricing power and cost discipline remain key pillars of its strategy.

P&G has held up well in a mixed consumer environment, benefiting from its exposure to everyday essentials and global scale. The company’s ability to maintain share across several categories, even amid softer volumes, has kept investor sentiment generally positive.

As earnings season approaches, analysts will be looking for commentary on volume recovery and input costs, particularly as inflation eases in certain regions. The new target reflects modest caution without undermining the firm’s broader bullish stance on P&G’s market positioning.

While we acknowledge the risk and potential of PG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PG and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Healthcare AI Stocks to Buy According to Hedge Funds and 10 Best Industrial Automation Stocks to Buy for the Next Decade

Disclosure: None.